Radiation Applications

Nuclear Medicine / NRG Pallas Boosts Lutetium Research For Cancer Treatment At Petten Reactor

By Kamen Kraev
6 February 2024

HFR currently among four facilities in Europe to supply medical isotopes

NRG Pallas Boosts Lutetium Research For Cancer Treatment At Petten Reactor
The HFR can provide medical radioisotopes for 40,000 patients per day. Courtesy NRG Pallas.
The High Flux Reactor (HFR) at Petten in the Netherlands has initiated its first cycle of 2024 focusing on irradiating lutetium for medical applications.

Want to know more?
Sign up.

Pen Use this content

Tags


Related